BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34187349)

  • 1. Danshensu alleviates bleomycin-induced pulmonary fibrosis by inhibiting lung fibroblast-to-myofibroblast transition via the MEK/ERK signaling pathway.
    Liu H; Zhang X; Shao Y; Lin X; Dong F; Liu X
    Bioengineered; 2021 Dec; 12(1):3113-3124. PubMed ID: 34187349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-fibrotic effect of iguratimod on pulmonary fibrosis by inhibiting the fibroblast-to-myofibroblast transition.
    Lin H; Wu C; Zhu F; Zhang G; Xie Y; Cui Y; Dong G; Zhang X
    Adv Med Sci; 2020 Sep; 65(2):338-347. PubMed ID: 32590154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
    Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
    Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP.
    Han YY; Gu X; Yang CY; Ji HM; Lan YJ; Bi YQ; Si R; Qu J; Cheng MH; Gao J
    J Cell Physiol; 2021 Nov; 236(11):7734-7744. PubMed ID: 34061990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin alleviates bleomycin-induced pulmonary fibrosis in rats.
    Guan R; Zhao X; Wang X; Song N; Guo Y; Yan X; Jiang L; Cheng W; Shen L
    Toxicol Lett; 2016 Nov; 262():161-172. PubMed ID: 27717887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
    Koo HY; El-Baz LM; House S; Cilvik SN; Dorry SJ; Shoukry NM; Salem ML; Hafez HS; Dulin NO; Ornitz DM; Guzy RD
    J Pathol; 2018 Sep; 246(1):54-66. PubMed ID: 29873400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of Ramelteon on bleomycin-induced pulmonary fibrosis in mice.
    Zhang L; Cheng T; Chen W; Zhong C; Li M; Xie Y; Deng Q; Wang H; Yang Z; Ju J; Liang H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4153-4163. PubMed ID: 38032492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
    Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
    Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO4 peptide targets myofibroblast ameliorates bleomycin-induced pulmonary fibrosis in mice through ECM-receptor interaction pathway.
    Han X; Yuan T; Zhang J; Shi Y; Li D; Dong Y; Fan S
    J Cell Mol Med; 2022 Jun; 26(11):3269-3280. PubMed ID: 35510614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G protein coupled receptor 41 regulates fibroblast activation in pulmonary fibrosis via Gα
    Ren Z; Pan X; Li J; Dong X; Tu X; Pan LL; Sun J
    Pharmacol Res; 2023 May; 191():106754. PubMed ID: 37019194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
    Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
    Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin ameliorates bleomycin-induced pulmonary fibrosis via activating NRF2 and inhibiting galectin-3 expression.
    Lan YJ; Cheng MH; Ji HM; Bi YQ; Han YY; Yang CY; Gu X; Gao J; Dong HL
    Acta Pharmacol Sin; 2023 May; 44(5):1029-1037. PubMed ID: 36333557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cepharanthine Ameliorates Pulmonary Fibrosis by Inhibiting the NF-κB/NLRP3 Pathway, Fibroblast-to-Myofibroblast Transition and Inflammation.
    Chen G; Li J; Liu H; Zhou H; Liu M; Liang D; Meng Z; Gan H; Wu Z; Zhu X; Han P; Liu T; Gu R; Liu S; Dou G
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
    Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
    J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Li A; Xiao X; Feng ZL; Chen X; Liu LJ; Lin LG; Lu JJ; Zhang LL
    Toxicol Appl Pharmacol; 2020 Jan; 389():114882. PubMed ID: 31953203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo.
    Löfdahl A; Rydell-Törmänen K; Müller C; Martina Holst C; Thiman L; Ekström G; Wenglén C; Larsson-Callerfelt AK; Westergren-Thorsson G
    Physiol Rep; 2016 Aug; 4(15):. PubMed ID: 27482070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.